You have followed a link to a page that does not exist yet. To create the page, start typing in the box below (see the help page for more info). If you are here by mistake, click your browser's back button.
Warning: You are recreating a page that was previously deleted.
You should consider whether it is appropriate to continue editing this page. The deletion and move log for this page are provided here for convenience:
- 16:48, 24 June 2024 Victor talk contribs deleted page University Cancer Institute Toulouse-Oncopole Trials (content was: "'''NCTID''': NCT06112314 '''Title''': IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) '''Study Summary''': This is a phase 3, randomized, controlled study of IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated advanced melanoma. '''Sponsor''':...", and the only contributor was "Woloski" (talk))
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
